Silence Therapeutics plc SLN
19.81 USD -0.01 (-0.05%)
Regular-session close
19.80 -0.01 -0.05%
After hours · Nov 19, 4:46 PM ET
19.81 Day range 19.83
4.19 52-week range 19.87
- YTD
- +225.82%
- 1 year
- +208.09%
SLN revenue history
Revenue is income from the company’s ordinary business activities.
559,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 559,000 | -42,699,000 | -98.71% |
| FY 2024 | 2024-12-31 | 43,258,000 | 11,615,000 | 36.71% |
| FY 2023 | 2023-12-31 | 31,643,000 | 9,988,000 | 46.12% |
| FY 2022 | 2022-12-31 | 21,655,000 | 6,136,250 | 39.54% |
| FY 2021 | 2021-12-31 | 15,518,750 | 8,670,000 | 126.59% |
| FY 2020 | 2020-12-31 | 6,848,750 | 6,543,750 | 2145.49% |
| FY 2019 | 2019-12-31 | 305,000 | 305,000 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-19T07:00:40.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
